LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published 6 hours ago
Registration Open
Technical Workshop for India-based Suppliers: Process Safety Management - Ankleshwar, India

Technical Workshop for India-based Suppliers: Process Safety Management - Ankleshwar, India

Conference | 16–17 Jul 2026

In the modern chemical and pharmaceutical landscape, reactive chemical hazards represent one of the most significant risks to process safety and business continuity. Undetected thermal instabilities or improperly sized relief systems can lead to catastrophic runaway reactions, resulting in loss of life, environmental damage, and total asset loss. This intensive two-day workshop, led by industry experts from Kaypear in collaboration with the PSCI, provides a comprehensive roadmap for identifying, quantifying, and mitigating reactive risks.

Registration Process
If you are interested in attending this workshop, please register your interest below. Registration does not guarantee a place. Your attendance will be confirmed in due course. Please note that attendance is limited to one person per organization.

Who should attend
As this is a core technical topic, professionals with the following qualifications and job roles are requested to register:

  • Process safety engineers/Chemical engineers in technology transfer, technical services, R&D, and process engineers with operations / technical back ground of more than 5 years is recommended.
  • Engineers in senior management involved in technical reviews

Day 1

  • 08:30-09:00: Registration, Networking, and Tea-Coffee
  • 09:00-09:15: PSCI India Connect Overview
  • 09:15-09:25: Context Setting / PSCI Audit Findings
  • 09:25-09:30: Speaker Introduction
  • 09:30-11:00: What reactive hazards are and why they matter with case studies: Examples of reactive hazard scenarios & Common types of reactive chemicals based on functional groups, chemical incompatibility, and thermal stability
  • 11:00-11: 15:Tea Break/Net working
  • 11:15-13:00: Testing and hazard evaluation using calorimetry (DSC, TGA, ARC, TMRad, ARSST, RC1, RC2, etc.)
    • Testing protocol and methods available
    • Limitation, advantage, and disadvantage of each type of calorimeter
    • Data interpretation of the thermal stability reports
  • 13:00-14:00: Lunch/Networking
  • 14:00-15:30: Development, calculation, and impact of heat of reaction, reaction rate, and TMRad with a workshop example
  • 15:30-15:45: High Tea/Networking
  • 15:45-17:00: Stossel’s Criticality Index, CCPS Probability vs Severity table - Sharing case studies - Optimization to safer criticality classes
  • 17:00-17:30: Day 1 Summary & Q&A

Day 2

  • 08:30-09:00: Registrations/Networking/Tea-Coffee
  • 09:00-09:15: Recap & Quiz
  • 09:15-11:15: Introduction to DIERS methodology and direct scale up
    • Test protocol for vent sizing using a workshop problem
    • Emergency Relief System (ERS) training for vent sizing using direct scale up
    • Scale up of high phi factor vs direct scale up
  • 11:15-11:30: Tea Break/Networking
  • 11:30-13:00: Credibility of external fire induced runaway reaction - Sizing for external fire scenario
  • 13:00-14:00: Lunch/Networking
  • 14:00-15:45: How to control reactive hazards, including:
    • Mode of operation depending on the reaction rate (Batch, Semi-Batch, Continuous)
    • Understanding the effect of temperature of no return (TNR)
    • Likelihood scale based on TMRad
    • Quench calculations and reaction termination chemicals
    • Vent sizing using direct scale up
    • Introduction of Modern DRIERS tools
  • 15:45-16:00: High Tea/Networking
  • 16:00-16:30: SRV/RD testing + frequency
    Type testing - Flow verification - Field observations + common issues
  • 16:30-17:00: Workshop Summary & Q&A

Speakers

Mr. Rahul Raman
Rahul Raman is Principal Engineer and Subject Matter Expert at Kaypear with over 19 years of global expertise in process safety management (PSM) across the United States, Mexico, China, South Korea, and India. A Chartered Chemical Engineer with a Master's degree from Carnegie Mellon University and a B.Tech in Chemical Engineering from Anna University, he specializes in emergency relief system design, technical process safety, and process safety management implementation. Rahul has successfully led major projects in oil and gas, petrochemical, and chemical industries, including relief system gap assessments, HAZOP studies, quantitative risk assessments, and implementing process safety standards.

Mr. Pramod Mekhya
Mr. Pramodbhai Mekhya is a seasoned Chemical Engineer and Process Safety Specialist with over 19 years of industrial experience spanning process development, process safety, scale-up, and advanced calorimetry techniques in the pharmaceutical and chemical industries.
He has extensive hands-on expertise in thermal hazard assessment, reaction calorimetry, adiabatic calorimetry, and process scale-up, supporting both R&D laboratories and manufacturing plants to design safer and more efficient chemical processes. He brings a rare combination of industrial manufacturing experience and advanced safety instrumentation expertise, enabling participants to gain practical insights into reaction hazard evaluation, calorimetry data interpretation, and safe process scale-up strategies.

If you have a PSCI account, please log in first so your information will be filled automatically.

All fields are required except where specified. Please enter all information in English.

Full Members

  • Abbott
  • Acino International AG
  • AstraZeneca
  • Aurobindo
  • BASF Pharma
  • Bayer
  • Becton Dickinson
  • Boehringer Ingelheim
  • Bristol Myers Squibb
  • Centrient Pharmaceuticals
  • Chiesi
  • Coloplast
  • Elanco Animal Health
  • Grunenthal GmbH
  • GSK
  • Haleon
  • Johnson & Johnson
  • Kenvue
  • Lilly
  • Merck & Co.
  • Novartis
  • Novo Nordisk
  • Opella
  • Organon
  • Orion
  • Par Health
  • Pfizer
  • Piramal
  • Roche
  • Sandoz
  • Sanofi
  • Sartorius
  • Takeda
  • Teva
  • UCB
  • Viatris
  • West Pharmaceutical Services Inc.
  • Zoetis

Associate Members

  • AbbVie
  • Alkem Laboratories
  • Almirall
  • Amgen
  • Amgros
  • Aragen Life Sciences Limited
  • Aspen Pharmacare
  • Bavarian Nordic
  • Baxter
  • Charles River Laboratories
  • Chugai Pharmaceutical
  • Cipla
  • CSL Limited
  • Eisai Co., Limited
  • Esteve
  • Evolan Pharma AB
  • Fabbrica Italiana Sintetici S.p.a.
  • Fagron
  • Fosun Pharma
  • Fresenius Kabi
  • Gilead
  • Grifols
  • Hameln Pharma
  • IOI Oleo
  • Karo Healthcare
  • Kyowa Kirin
  • Merck KGaA
  • Moderna
  • Ono Pharmaceuticals
  • Orifarm
  • Perrigo Company
  • Polpharma
  • Regeneron
  • Sai Life Sciences
  • Server Pharma Solutions
  • Servier
  • Shionogi
  • SK Biopharmaceuticals
  • Sobi
  • STADA
  • Sterling Pharma Solutions
  • ten23 health
  • Tiefenbacher Group
  • Vantive
  • Vertex
  • Xellia Pharmaceuticals
  • Zentiva

We will not pass on these details to third parties and will use them only to contact you about this event, or other PSCI events we think you may be interested in.

Please contact us if you find you can no longer attend.

I understand that these details will be used by the PSCI to identify me and to send me communications relating to this, and future, PSCI events.

Leave this field blank if you are a human.
Registration Closes: 10 Jul 2026
If you have a user account, please log in before registering.
This resource was published on 11 June
PSCI Supplier Newsletter June 2026

PSCI Supplier Newsletter June 2026

Get a quick update on the latest PSCI news, including the PSCI Annual Report, 2025 Audit Findings Analysis, CPHI China and Korea, and more.

This bulletin was published on 11 June

New guidance published: April 2027 milestone of the NHS Net Zero Supplier Roadmap

NHS England has published new guidance setting out what suppliers need to do from April 2027 as part of the NHS Net Zero Supplier Roadmap – their shared commitment to reaching net zero by 2045.

From 1st April 2027, the NHS will implement new proportionate requirements for suppliers to publicly report targets, emissions and publish the Carbon Reduction Plan for all of their relevant global scope 1, 2 and 3 emissions.

Following extensive engagement with stakeholders, NHS England has now published the guidance, 2027 NHS Carbon reduction plan requirements for the procurement of NHS goods, services and works along with the Market sounding findings: net zero supplier requirements from April 2027. Together, these documents set out the approach to Scope 3 target setting and reporting, and outline how stakeholder feedback has informed the final policy approach.

The development of this guidance has been a collaborative effort and builds on the feedback received through engagement activities. It supports delivery of the NHS’s net zero commitment, as set out in Delivering a Net Zero National Health Service, whilst providing clarity for procurement teams and suppliers on what is required and how to prepare for the requirements that will go live from April 2027.

Suppliers can utilize available support to meet the requirements through:

This bulletin was published on 2 June
Global Audit Insights: PSCI Audit Findings Analysis 2025

Global Audit Insights: PSCI Audit Findings Analysis 2025

THE PSCI PRESENTS ITS ANNUAL PUBLIC AUDIT FINDINGS REPORT, PROVIDING CONTINUED INSIGHTS AND REVIEW OF SUPPLIER PRACTICES, REFLECTING THE COMMITMENT OF THE PSCI AND ITS MEMBERS TO A RESPONSIBLE, RESILIENT PHARMACEUTICAL AND HEALTHCARE SUPPLY CHAIN.

The PSCI’s audit findings are analyzed to identify trends, highlight improvements, and share recommendations. The analysis provides deep insight into supplier practices within the pharmaceutical and healthcare industry. In 2025, pharmaceutical and healthcare companies carried out thousands of supplier site audits, each typically representing two to four days of dedicated on-site work from both auditors and suppliers. Members of the PSCI collaborate by sharing these audits, with their suppliers’ permission, promoting greater transparency and creating efficiencies that benefit all parties involved.

In 2025, Members and suppliers uploaded a record number of over 240 audits to the PSCI platform, reflecting a significant collective effort. These audits generated more than 2,500 findings identified by auditors across the five PSCI Principles: Governance & Management Systems, Ethics, Human Rights, Environment, and Health & Safety. The analysis presented in this report offers a snapshot of suppliers’ real-world practices, highlighting recurring challenges and identifying areas where joint action can deliver the greatest impact.

The report is structured in three parts:

  1. A deep dive exploring the most common findings within each Principle, supported by qualitative examples from auditor observations.
  2. A regional analysis looking at patterns in China, India, the United States, Western Europe, and other regions.
  3. An insights section further interpreting findings from the perspectives of supplier categories, audit topic coverage, and onsite vs remote audits.

The report identifies several key trends across the PSCI Principles:

  • Health & Safety remains the largest source of findings by volume, reflecting consistent auditor focus on this business-critical and potentially life-threatening topic.
  • Environment findings nearly doubled, from 221 in 2024 to 435 in 2025, with Waste & Emissions as the largest sub-topic.
  • Governance & Management Systems and Human Rights findings decreased, showing a slight shift of audit focus towards topics like hazardous waste handling and associated vendor qualification, as well as API discharge risk assessment.
  • Relatively small number of Human Rights findings, especially for topics related to Wage, Benefits, & Working Hours, were recorded at a high severity level, which flags basic labor practices as an important management theme for suppliers.

Birgit Skuballa, Co-lead of the PSCI Audit Committee and Director of ESG Governance at Bayer reflected on this year’s findings.

“What stands out to me in this report is not only the scale of the effort behind these audits, but also the opportunity they create. Every finding tells us something important about where suppliers are making progress and where more support is needed. By sharing insights, identifying common challenges, and providing support through conferences, webinars, training materials, and practical tools, we can move beyond individual findings and drive broader, more consistent improvement across global pharmaceutical supply chains.”

The Audit Findings Analysis report demonstrates the PSCI Members’ shared goal to translate audit evidence into actionable insights. These insights prioritize the PSCI’s provision of supplier training topics, practical guidance, and collaboration with regional partners, ultimately supporting safer work, stronger rights, reduced environmental impact, and responsible business conduct across global supply chains.

For more details, access the full report in the resource attached.

  • Audit Program
This event was published on 1 June
CPHI Korea

CPHI Korea

External | 25–27 Aug 2026

PSCI is delighted to be an Official Sustainability Partner to CPHI Korea for the very first time

CPHI Korea is a dynamic meeting place where pharmaceutical suppliers, purchasers and decision makers get together for three days of uninterrupted business. Exhibiting companies showcase products from across the entire pharma supply chain: from ingredients and contract services, through to machinery and biopharmaceuticals.

Watch this space for more information about PSCI's participation.

Pre-register for the event here.

Type
External
Date
25–27 Aug 2026
Language
English
This bulletin was published on 1 June
PSCI Members to speak at CPHI & PMEC China 2026

PSCI Members to speak at CPHI & PMEC China 2026

Looking to CPHI China & PMEC China 2026, we’re excited to be part of one of the biggest gatherings across the global pharma supply chain, taking place 16–18 June in Shanghai.

As an Official Sustainability Partner of CPHI, PSCI Members will be actively contributing across the event:

  • Boyu Han (AstraZeneca) will present “Zero-Carbon Factory Construction and Energy-Saving Practices for Manufacturing Enterprises” at the Energy Saving & Carbon Reduction Symposium (17 June)
  • Richard Sun (GSK) will present “Equipment Safety Upgrades” at the Pharmaceutical Plant & Upgrade Forum (17 June)
  • Richard Sun will also join the 2026 CPHI China Awards - Sustainable Awards Ceremony as a judge (16 June)

If you’re planning to attend, you can register for free via the link below. We hope to see you there!

Learn more and register here.

This event was published on 28 May
Registration Open
PSCI Webinar - Elevating Fire & Life Safety in Pharma: An overview of the New NBCS 2026

PSCI Webinar - Elevating Fire & Life Safety in Pharma: An overview of the New NBCS 2026

Webinar | 30 Jun 2026 14:30–16:00 Kolkata

What to expect:
India recently transitioned from the National Building Code (NBC 2016) to the newly notified National Building Construction Standards (NBCS) 2026. This signifies an evolution in India’s strategy for fire and life safety with a modernized approach to safety and compliance.

Fire safety is a critical aspect for pharmaceutical industry and PSCI audits have identified significant gaps in this area. This webinar will cover NBCS 2026 compliance, focusing on fire detection and fire protection systems, including critical gaps in inspection and maintenance of these systems. The webinar is highly relevant for pharmaceutical suppliers to strengthen risk management, ensure regulatory compliance, and address safety gaps in high-risk environments, ultimately protecting assets, operations, and people.

Speakers:
Dr. Aleem Basha M is an experienced EHS consultant with over 18 years of expertise in safety consulting, audits, and risk management. He is an engineer and an IRCA-certified OHSAS 18001 Lead Auditor. His expertise spans process safety, HAZOP, PSM, fire and electrical risk assessments, hazardous area classification, and industrial hygiene. He has worked across industries including pharmaceuticals, chemicals, power, and construction. He also delivers EHS trainings on safety leadership, fire safety, and process safety, across South Asia and the Middle East.

Who should attend:
HSE & Process safety, Engineering & Maintenance, Projects, Electrical & Utilities, Legal and Compliance, Site management, Facility Management personnel will benefit from joining the webinar

Type
Webinar
Date
30 Jun 2026 14:30–16:00 Kolkata
Language
English
Registration Closes: 29 Jun 2026
If you have a user account, please log in before registering.
  • Health & Safety
This event was published on 8 May
CPHI & PMEC China
CPHI

CPHI & PMEC China

External | 16–18 Jun 2026

CPHI & PMEC China brings together suppliers and buyers across the entire pharma supply chain, in the home of modern medicine. Position your business as a key player in a thriving market and access a market built on rapid innovation. Join us in Shanghai to network, source cost-effective solutions, and conduct vital face-to-face business.

PSCI Members will be speaking at the event. For more information, check out the agenda.

Type
External
Date
16–18 Jun 2026
Language
English
This event is in the past
This resource was published on 6 May

PSCI Members showcase shared impact at 2026 Member Meeting

Video

The PSCI Spring Meeting 2026 took place on the 21st and 22nd of April in Basel, Switzerland, hosted by Roche. We were joined by 180 members, both in-person and virtually, to explore this year's theme of Transformational Impact.

Recordings and the report back are available to PSCI Members.

This event was published on 4 May
CPHI Milan 2026

CPHI Milan 2026

External | 6–8 Oct 2026

The PSCI is delighted to be an Official Sustainability Partner for CPHI Milan, the biggest international pharma industry event.

We'll be exhibiting throughout the conference in Milan from 6-8 October, and attending the inaugural CPHI Sustainability Summit on Monday 5 October.

The PSCI stand H47 will be located in Hall 16, where we will be showcasing the impact that the PSCI has through the pharmaceutical supply chain.

Meet with us on-site
Please contact the Secretariat if you are planning to attend and would like to arrange a meeting.

Type
External
Date
6–8 Oct 2026
Venue
Language
English